Neuroprotective Marine Bioactives: Ocean-Derived Compounds for Targeting CNS Disorders
暫譯: 神經保護海洋生物活性物質：針對中樞神經系統疾病的海洋衍生化合物

Dr. Mullaicharam Bhupathyraaj is a Professor of Pharmaceutics at the College of Pharmacy, National University of Science and Technology, Sultanate of Oman. With more than two decades of academic and research excellence, she has made significant contributions to biomedicine, nanopharmaceuticals, herbal formulation development, and artificial intelligence-driven drug delivery systems. She holds ten international patents, numerous publications in high-impact journals, and has received multiple national and international research grants. She serves as external reviewer for the Oman Academic Accreditation Authority and MoHERI-funded research projects and has been a judge for the global Reimagine Education Awards. A registered pharmacist and life member of IPA, APTI, IPGA, and ISTE, she is recognized for her leadership in advancing pharmaceutical innovation and sustainable healthcare.

Dr. K. Reeta Vijayarani is a Professor in the Pharmaceutics Department of Surya School of Pharmacy in Vikravandi, Villupuram, Afffiliaed to The TN Dr. M.G.R. Medical University, Chennai. She has combined experience of 29 years in Pharmaceutical research and education, and she has authored and presented papers at both the national and international levels. Prof. Reeta has built a distinguished career marked by an extensive research portfolio that includes numerous publications, both national and international patents, and the authorship of multiple textbooks and serving as an editorial board member and a reviewer in various peer-reviewed books and journals. Her work has made substantial contributions to pharmaceutical formulations, innovative drug delivery systems, and the integration of Artificial Intelligence in pharmacy. Her research is deeply rooted in the exploration of biodiversity and the development of novel therapeutic techniques.

Dr. Muralikrishnan Dhanasekaran, M.Pharm., PG.DPM&IR, Ph.D., is an Alumni Professor and Administrative Fellow in the Graduate School at Auburn University, USA. He has mentored numerous undergraduates, Honors College, graduate, and professional (Pharm.D.) students, and has authored nearly 160 peer-reviewed international publications, over 500 scientific abstracts, nearly 80 book chapters, and has served as Editor for more than twelve scientific books. He is also an active reviewer for multiple international journals and grant agencies. His research laboratory focuses on preclinical neuropharmacology and drug development, particularly investigating the neuroprotective and neurotoxic effects of natural bioactives and synthetic molecules. His current research aims to discover and develop novel therapeutic agents targeting epilepsy, Alzheimer's disease, and Parkinson's disease.

Dr. Kalandar Ameer is a highly accomplished Senior Associate Professor of Biochemistry with a distinguished career spanning academia and research across international institutions. Currently he is working in the Faculty of Medicine at AIMST University, Malaysia. Prior to this appointment, he served as Associate Professor of Biochemistry under the UNDP expatriate program at two prominent public universities within the Ethiopian Ministry of Higher Education from 2019 to 2024. His foundational academic and professional experiences were cultivated in various Indian universities from 1996 to 2008.

Dr. Dua has a research experience of over 16 years working in the field of Targeted Drug Delivery for Inflammatory Diseases. Dr Dua is also a Node Leader of Drug Delivery Research in the Centre for Inflammation at Centenary Institute/UTS, where the targets identified from the research projects are pursued to develop novel formulations as the first step towards translation into clinics. Dr Dua's research is in two complementary areas; drug delivery and immunology, specifically addressing how these disciplines can advance one another helping the community to live longer and healthier. This is evidenced by his extensive publication record in reputed journals.

穆萊查拉姆·布哈帕提拉教授（Dr. Mullaicharam Bhupathyraaj）是阿曼蘇丹國國立科技大學藥學院的藥劑學教授。她擁有超過二十年的學術和研究卓越經歷，對生物醫學、奈米藥物、草藥配方開發以及人工智慧驅動的藥物傳遞系統做出了重要貢獻。她擁有十項國際專利，並在高影響力期刊上發表了多篇論文，獲得多項國內和國際研究資助。她擔任阿曼學術認證機構和MoHERI資助研究項目的外部審查員，並曾擔任全球再想像教育獎的評審。作為註冊藥劑師及IPA、APTI、IPGA和ISTE的終身會員，她因在推動藥物創新和可持續醫療保健方面的領導力而受到認可。

K. 瑞塔·維賈亞拉尼教授（Dr. K. Reeta Vijayarani）是印度金奈TN Dr. M.G.R.醫科大學附屬的維克拉萬迪蘇利亞藥學院藥劑學系的教授。她在藥物研究和教育方面擁有29年的綜合經驗，並在國內外發表和報告了多篇論文。瑞塔教授的職業生涯卓越，擁有廣泛的研究作品，包括多篇國內外出版物、專利以及多本教科書的著作，並在各種同行評審的書籍和期刊中擔任編輯委員會成員和審稿人。她的工作對藥物配方、創新藥物傳遞系統以及人工智慧在藥學中的整合做出了重要貢獻。她的研究深植於生物多樣性的探索和新型治療技術的開發中。

穆拉利克里希南·達納塞卡蘭博士（Dr. Muralikrishnan Dhanasekaran），M.Pharm., PG.DPM&IR, Ph.D.，是美國奧本大學研究生院的校友教授和行政研究員。他指導了眾多本科生、榮譽學院、研究生和專業（Pharm.D.）學生，並發表了近160篇同行評審的國際出版物、超過500篇科學摘要、近80章書籍，並擔任超過十二本科學書籍的編輯。他還是多個國際期刊和資助機構的活躍審稿人。他的研究實驗室專注於臨床前神經藥理學和藥物開發，特別是研究天然生物活性物質和合成分子的神經保護和神經毒性效應。他目前的研究旨在發現和開發針對癲癇、阿茲海默症和帕金森病的新型治療劑。

卡蘭達·阿米爾博士（Dr. Kalandar Ameer）是一位成就卓越的生物化學高級副教授，擁有跨國機構的學術和研究經歷。目前他在馬來西亞AIMST大學醫學院工作。在此之前，他於2019年至2024年期間，作為聯合國開發計劃署（UNDP）外派計劃的生物化學副教授，在埃塞俄比亞高等教育部的兩所著名公立大學任教。他的基礎學術和專業經驗是在1996年至2008年期間於多所印度大學培養的。

杜阿博士（Dr. Dua）在針對炎症性疾病的靶向藥物傳遞領域擁有超過16年的研究經驗。杜阿博士還是百年研究所/UTS炎症中心藥物傳遞研究的節點負責人，該中心的研究項目所識別的目標將被追求以開發新型配方，作為轉化到臨床的第一步。杜阿博士的研究涵蓋兩個互補領域：藥物傳遞和免疫學，特別是探討這些學科如何相互促進，幫助社區過上更長久和健康的生活。這一點在他在知名期刊上的廣泛出版記錄中得到了證明。